Bridge City Capital’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43M | Sell |
19,542
-22,487
| -54% | -$1.65M | 0.4% | 90 |
|
|
2025
Q1 | $4.8M | Sell |
42,029
-15,863
| -27% | -$1.81M | 1.44% | 20 |
|
|
2024
Q4 | $2.92M | Buy |
57,892
+518
| +0.9% | +$26.1K | 0.78% | 57 |
|
|
2024
Q3 | $2.66M | Buy |
57,374
+8,137
| +17% | +$377K | 0.73% | 65 |
|
|
2024
Q2 | $1.6M | Sell |
49,237
-401
| -0.8% | -$13K | 0.54% | 80 |
|
|
2024
Q1 | $1.25M | Buy |
49,638
+386
| +0.8% | +$9.72K | 0.46% | 88 |
|
|
2023
Q4 | $1.6M | Buy |
49,252
+5,767
| +13% | +$187K | 0.62% | 78 |
|
|
2023
Q3 | $1.18M | Sell |
43,485
-17,147
| -28% | -$467K | 0.6% | 80 |
|
|
2023
Q2 | $1.35M | Buy |
60,632
+35
| +0.1% | +$779 | 0.64% | 74 |
|
|
2023
Q1 | $1.31M | Sell |
60,597
-227
| -0.4% | -$4.92K | 0.66% | 76 |
|
|
2022
Q4 | $1.24M | Sell |
60,824
-430
| -0.7% | -$8.73K | 0.63% | 79 |
|
|
2022
Q3 | $1.57M | Sell |
61,254
-22,564
| -27% | -$579K | 0.86% | 54 |
|
|
2022
Q2 | $1.99M | Sell |
83,818
-149
| -0.2% | -$3.54K | 1.05% | 44 |
|
|
2022
Q1 | $1.89M | Sell |
83,967
-441
| -0.5% | -$9.93K | 0.88% | 55 |
|
|
2021
Q4 | $1.67M | Sell |
84,408
-15
| -0% | -$297 | 0.69% | 73 |
|
|
2021
Q3 | $1.66M | Sell |
84,423
-22,515
| -21% | -$443K | 0.75% | 69 |
|
|
2021
Q2 | $2.35M | Sell |
106,938
-3,574
| -3% | -$78.6K | 0.8% | 63 |
|
|
2021
Q1 | $2.63M | Sell |
110,512
-1,127
| -1% | -$26.8K | 0.87% | 53 |
|
|
2020
Q4 | $2.92M | Sell |
111,639
-1,159
| -1% | -$30.3K | 1.11% | 44 |
|
|
2020
Q3 | $1.96M | Buy |
112,798
+21,938
| +24% | +$382K | 0.94% | 53 |
|
|
2020
Q2 | $1.53M | Buy |
+90,860
| New | +$1.53M | 0.7% | 68 |
|